Despite its mixed financial performance in recent quarters, BMO’s consistent focus on long-term growth initiatives and U.S.

BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) shares, maintaining an Outperform rating and a $105.00 price target. This confirmation followed the U.S. Food and Drug ...

The Canada-based bank dismissed the leader from its capital markets arm following a multimillion-dollar penalty to settle ...

Bank of Montreal dismissed a managing director on its US mortgage-backed bond desk in connection with a regulatory probe into ...

California has a history of attracting outsiders, whether it’s the beaches, the promise of Hollywood, the national parks or ...

The BTS member is heading on an international run for his first-ever solo tour between February and June, and tickets are ...

Zelle r has been selected as the operating partner by Värde Partners and Trimont on two Chicago and one Indianapolis office ...

We recently compiled a list of the 10 Tech Stocks to Sell Now According to Cathie Wood. In this article, we are going to take ...

His son, Doug Schmaus, said his dad set aside money to pay for his burial expenses in an account at Bank of the West 15-20 years ago. But when Richard passed away early last year and Doug went to pull ...

Canadian consumers appear to have embraced falling interest rates and ended the holiday season with the strongest spending in nearly two years.

BMO Capital raised the firm’s price target on Vistra (VST) to $191 from $151 and keeps an Outperform rating on the shares. The impact of the ...

BMO Capital says Belarusian potash supplier Belaruskali is cutting 1 metric ton of potash production in the first half of 2025 for efficiency ...